Is Gelesis Holdings, Inc. (GLS) a Buy, Sell, or Hold?
NYSE : GLS
Gelesis Holdings, Inc.
$0.1586 USD
$0 (0.0%)
- Volume
- 185.17K
- Average Volume
- 570.67K
- Market Capitalization
- $11.63M
- P/E Ratio
- -0.20
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $5.67
- Year Low
- $0.01
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.46
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
27
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
1
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$333.39K
GLS Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
GLS Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| PureTech Health plc | 10 percent owner | 2023-09-20 | P-Purchase | 0.0494 | 2023-09-21 |
| PureTech Health plc | 10 percent owner | 2023-06-12 | P-Purchase | 0.0134 | 2023-06-14 |
| PureTech Health plc | 10 percent owner | 2023-05-26 | P-Purchase | 0.0142 | 2023-05-31 |
| PureTech Health plc | 10 percent owner | 2023-05-26 | P-Purchase | 0.0142 | 2023-05-31 |
| PureTech Health plc | 10 percent owner | 2023-05-01 | P-Purchase | 0.0182 | 2023-05-03 |
| PureTech Health plc | 10 percent owner | 2023-05-01 | P-Purchase | 0.2744 | 2023-05-03 |
| PureTech Health plc | 10 percent owner | 2023-05-01 | P-Purchase | 0.2744 | 2023-05-03 |
| PureTech Health plc | 10 percent owner | 2023-05-01 | P-Purchase | 0.0182 | 2023-05-03 |
| KUCHERLAPATI RAJU S | director | 2022-11-21 | P-Purchase | 0.45 | 2022-11-22 |
| KUCHERLAPATI RAJU S | director | 2022-11-18 | P-Purchase | 0.39 | 2022-11-22 |
| KUCHERLAPATI RAJU S | director: | 2022-06-15 | P-Purchase | 1.9471 | 2022-06-17 |
| Sannino Alessandro | director: Lead Project Scientist | 2022-06-08 | A-Award | 0 | 2022-06-13 |
| Sannino Alessandro | director: Lead Project Scientist | 2022-06-08 | D-Return | 0 | 2022-06-13 |
| Chiquette Elaine | director: Chief Scientific Officer | 2022-06-08 | A-Award | 0 | 2022-06-10 |
| Zohar Yishai | officer: President & CEO | 2022-05-06 | A-Award | 0 | 2022-05-09 |
| Wildman Jane | director: | 2022-05-06 | A-Award | 0 | 2022-05-09 |
| Sannino Alessandro | officer: Lead Project Scientist | 2022-05-06 | A-Award | 0 | 2022-05-09 |
| Perks Dominic | director: | 2022-05-06 | A-Award | 0 | 2022-05-09 |
| Pass David A. | officer: Chief Operating Officer | 2022-05-06 | A-Award | 0 | 2022-05-09 |
| Maltz Elliot | officer: Chief Financial Officer | 2022-05-06 | A-Award | 0 | 2022-05-09 |
| Leider Harry L. | officer: Chief Medical Officer | 2022-05-06 | A-Award | 0 | 2022-05-09 |
| KUCHERLAPATI RAJU S | director: | 2022-05-06 | A-Award | 0 | 2022-05-09 |
| FONTEYNE PAUL R. | director: | 2022-05-06 | A-Award | 0 | 2022-05-09 |
| Christopher Clayton | director: | 2022-05-06 | A-Award | 0 | 2022-05-09 |
| Chiquette Elaine | officer: Chief Scientific Officer | 2022-05-06 | A-Award | 0 | 2022-05-09 |
| Abraham David | officer: General Counsel | 2022-05-06 | A-Award | 0 | 2022-05-09 |
| Abraham David | officer: General Counsel | 2022-05-06 | A-Award | 3.33 | 2022-05-09 |
| Abraham David | officer: General Counsel | 2022-05-06 | A-Award | 0 | 2022-05-09 |
| Abraham David | officer: General Counsel | 2022-05-06 | A-Award | 0 | 2022-05-09 |
| Cavanaugh Kathryn | director: | 2022-05-06 | A-Award | 0 | 2022-05-09 |
| Bauerlein Alison | director: | 2022-05-06 | A-Award | 0 | 2022-05-09 |
| Zohar Yishai | director, officer: President & CEO | 2022-01-13 | 0 | 2022-01-24 | |
| Zohar Yishai | director, officer: President & CEO | 2022-01-13 | 0 | 2022-01-24 | |
| Zohar Yishai | director, officer: President & CEO | 2022-01-13 | 0.57 | 2022-01-24 | |
| Zohar Yishai | director, officer: President & CEO | 2022-01-13 | 3.11 | 2022-01-24 | |
| Zohar Yishai | director, officer: President & CEO | 2022-01-13 | 4.26 | 2022-01-24 | |
| Zohar Yishai | director, officer: President & CEO | 2022-01-13 | 0 | 2022-01-24 | |
| Zohar Yishai | director, officer: President & CEO | 2022-01-13 | 4.05 | 2022-01-24 | |
| Wildman Jane | director | 2022-01-13 | 0 | 2022-01-24 | |
| Wildman Jane | director | 2022-01-13 | 5.56 | 2022-01-24 | |
| Sannino Alessandro | officer: Lead Project Scientist | 2022-01-13 | 0 | 2022-01-24 | |
| Sannino Alessandro | officer: Lead Project Scientist | 2022-01-13 | 0 | 2022-01-24 | |
| Sannino Alessandro | officer: Lead Project Scientist | 2022-01-13 | 0.22 | 2022-01-24 | |
| Sannino Alessandro | officer: Lead Project Scientist | 2020-10-28 | 4.26 | 2022-01-24 | |
| Sannino Alessandro | officer: Lead Project Scientist | 2022-01-13 | 0 | 2022-01-24 | |
| Sannino Alessandro | officer: Lead Project Scientist | 2022-01-13 | 0.57 | 2022-01-24 | |
| Sannino Alessandro | officer: Lead Project Scientist | 2022-01-13 | 0 | 2022-01-24 | |
| Perks Dominic | director: | 2022-01-13 | 0 | 2022-01-24 | |
| Pass David A. | officer: Chief Op. & Comm. Officer | 2022-01-13 | 4.05 | 2022-01-24 | |
| Pass David A. | officer: Chief Op. & Comm. Officer | 2022-01-13 | 4.26 | 2022-01-24 | |
| Pass David A. | officer: Chief Op. & Comm. Officer | 2022-01-13 | 0 | 2022-01-24 | |
| Maltz Elliot | officer: CFO & Treasurer | 2022-01-13 | 0 | 2022-01-24 | |
| Maltz Elliot | officer: CFO & Treasurer | 2022-01-13 | 4.26 | 2022-01-24 | |
| Maltz Elliot | officer: CFO & Treasurer | 2022-01-13 | 5.56 | 2022-01-24 | |
| Maltz Elliot | officer: CFO & Treasurer | 2022-01-13 | 3.11 | 2022-01-24 | |
| Maltz Elliot | officer: CFO & Treasurer | 2022-01-13 | 4.05 | 2022-01-24 | |
| Leider Harry L. | officer: Chief Medical Officer | 2022-01-13 | 0 | 2022-01-24 | |
| Leider Harry L. | officer: Chief Medical Officer | 2022-01-13 | 4.26 | 2022-01-24 | |
| Leider Harry L. | officer: Chief Medical Officer | 2022-01-13 | 4.05 | 2022-01-24 | |
| FONTEYNE PAUL R. | director | 2022-01-13 | 0 | 2022-01-24 | |
| FONTEYNE PAUL R. | director | 2022-01-13 | 4.05 | 2022-01-24 | |
| FONTEYNE PAUL R. | director | 2022-01-13 | 4.26 | 2022-01-24 | |
| FONTEYNE PAUL R. | director | 2022-01-13 | 5.56 | 2022-01-24 | |
| Christopher Clayton | director: | 2022-01-13 | 0 | 2022-01-24 | |
| Chiquette Elaine | officer: Chief Scientific Officer | 2022-01-13 | 4.26 | 2022-01-24 | |
| Chiquette Elaine | officer: Chief Scientific Officer | 2022-01-13 | 0 | 2022-01-24 | |
| Chiquette Elaine | officer: Chief Scientific Officer | 2022-01-13 | 4.05 | 2022-01-24 | |
| Bauerlein Alison | director | 2022-01-13 | 8.26 | 2022-01-24 | |
| Bauerlein Alison | director | 2022-01-13 | 0 | 2022-01-24 | |
| Abraham David | officer: Genrl Counsel, CCO & Secretary | 2022-01-13 | 9.46 | 2022-01-24 | |
| Abraham David | officer: Genrl Counsel, CCO & Secretary | 2022-01-13 | 0 | 2022-01-24 | |
| Abraham David | officer: Genrl Counsel, CCO & Secretary | 2022-01-13 | 4.26 | 2022-01-24 | |
| SSD2, LLC | 10 percent owner | 2022-01-13 | 0 | 2022-01-21 | |
| SSD2, LLC | 10 percent owner | 2022-01-13 | 0 | 2022-01-21 | |
| SSD2, LLC | 10 percent owner | 2022-01-13 | 0 | 2022-01-21 | |
| SSD2, LLC | 10 percent owner | 2022-01-13 | 0 | 2022-01-21 | |
| SSD2, LLC | 10 percent owner | 2022-01-13 | 0 | 2022-01-21 | |
| PureTech Health plc | 10 percent owner | 2022-01-13 | 0 | 2022-01-21 | |
| PureTech Health plc | 10 percent owner | 2022-01-13 | 4.05 | 2022-01-21 | |
| PureTech Health plc | 10 percent owner | 2022-01-13 | 0 | 2022-01-21 | |
| PureTech Health plc | 10 percent owner | 2022-01-13 | 0.02 | 2022-01-21 | |
| HPSO SPV Ltd | 10 percent owner | 2022-01-13 | 0 | 2022-01-21 | |
| HPSO SPV Ltd | 10 percent owner | 2022-01-13 | 0 | 2022-01-21 | |
| KUCHERLAPATI RAJU S | director | 2022-01-14 | P-Purchase | 6.67 | 2022-01-19 |
| KUCHERLAPATI RAJU S | director: | 2022-01-13 | 0 | 2022-01-19 | |
| Cavanaugh Kathryn | director | 2022-01-13 | J-Other | 0 | 2022-01-18 |
| Cavanaugh Kathryn | director | 2022-01-13 | J-Other | 0 | 2022-01-18 |
| Cavanaugh Kathryn | director | 2022-01-13 | M-Exempt | 0 | 2022-01-18 |
| Cavanaugh Kathryn | director | 2022-01-13 | J-Other | 0 | 2022-01-18 |
| Cavanaugh Kathryn | director | 2022-01-13 | M-Exempt | 0 | 2022-01-18 |
| Ghiselli John | director | 2020-07-06 | P-Purchase | 10.2564 | 2020-07-08 |
| Weinstein Jamie M. | director: | 2020-07-01 | 0 | 2020-07-01 | |
| de la Torre Rodrigo | director: | 2020-07-01 | 0 | 2020-07-01 | |
| Whittenburg James S.B. | director | 2020-07-01 | 0 | 2020-07-01 | |
| Hicks Robert Steven | director, 10 percent owner, officer: Chairman, CEO and CFO | 2020-07-01 | 0 | 2020-07-01 | |
| Ghiselli John | director | 2020-07-01 | 0 | 2020-07-01 | |
| Capstar Sponsor Group, LLC | 10 percent owner | 2020-07-01 | 0 | 2020-07-01 | |
| Cavanaugh Kathryn | director | 2020-07-01 | 0 | 2020-07-01 |